These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 214196)

  • 1. Effect of acute and chronic amphetamine administration on beta-adrenoceptors and dopamine receptors in rat corpus striatum and limbic forebrain [proceedings].
    Howlett DR; Nahorski SR
    Br J Pharmacol; 1978 Nov; 64(3):411P-412P. PubMed ID: 214196
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the effects of (-)deprenyl, 1-phenyl-2-propyl-aminopentane (MK-306) and amphetamine on the striatal and limbic dopaminergic system.
    Timár J; Yasar S; Knoll B; Knoll J
    Acta Physiol Hung; 1990; 75 Suppl():279-80. PubMed ID: 2115233
    [No Abstract]   [Full Text] [Related]  

  • 3. High doses of morphine do not change characteristics of the cerebral catecholamine receptors in the rat.
    Rokosz-Kozłowska A; Antkiewicz-Michaluk L; Vetulani J
    Pol J Pharmacol Pharm; 1988; 40(4):387-92. PubMed ID: 2851780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of long-term neuroleptic administration on CNS receptors plasticity].
    Allikmets LKh; Zharkovskiĭ AM; Nurk AM; Vasar EE; Maĭmets MO
    Vestn Akad Med Nauk SSSR; 1984; (11):37-42. PubMed ID: 6152099
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
    [No Abstract]   [Full Text] [Related]  

  • 6. Similarities and differences of dopamine receptors in the renal vascular bed and elsewhere.
    Goldberg LI; Volkman PH; Kohli JD; Kotake AN
    Adv Biochem Psychopharmacol; 1977; 16():251-6. PubMed ID: 196488
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Amphetamine and apomorphine responses in the rat after lesion of mesolimbic or striatal dopamine neurones.
    Iversen SD; Kelly PH; Miller RJ; Seviour P
    Br J Pharmacol; 1975 Jun; 54(2):244P. PubMed ID: 1148532
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistence of beta-adrenergic receptors in rat striatum following kainic acid administration.
    Zahniser NR; Minneman KP; Molinoff PB
    Brain Res; 1979 Dec; 178(2-3):589-95. PubMed ID: 228797
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 10. Repeated amphetamine administration alters the interaction between D1-stimulated adenylyl cyclase activity and calmodulin in rat striatum.
    Roseboom PH; Hewlett GH; Gnegy ME
    J Pharmacol Exp Ther; 1990 Oct; 255(1):197-203. PubMed ID: 2145422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists.
    Pitts DK; Kelland MD; Freeman AS; Chiodo LA
    J Pharmacol Exp Ther; 1993 Feb; 264(2):616-21. PubMed ID: 8094749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the preferential release of mesolimbic dopamine by amphetamine.
    Di Chiara G
    Neuropsychopharmacology; 1991 Dec; 5(4):243-7. PubMed ID: 1804162
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion.
    Broderick PA; Gardner EL; van Praag HM
    Biol Psychiatry; 1984 Jan; 19(1):45-54. PubMed ID: 6538442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of limbic dopamine levels to amphetamine- and anticholinergic-induced hyperactivity in the rat.
    Carey RJ
    Biol Psychiatry; 1986 Mar; 21(3):317-21. PubMed ID: 3081055
    [No Abstract]   [Full Text] [Related]  

  • 15. Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration.
    Barnett JV; Kuczenski R
    J Pharmacol Exp Ther; 1986 Jun; 237(3):820-5. PubMed ID: 2940359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated amphetamine pretreatment alters the responsiveness of striatal dopamine-stimulated adenylate cyclase to amphetamine-induced desensitization.
    Barnett JV; Segal DS; Kuczenski R
    J Pharmacol Exp Ther; 1987 Jul; 242(1):40-7. PubMed ID: 2956412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
    Hertel P
    Synapse; 2006 Dec; 60(7):543-52. PubMed ID: 16952163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect evidence for a feedback loop mechanism between two central dopaminergic pathways: preliminary results.
    Yehuda S
    Commun Psychopharmacol; 1979; 3(2):115-9. PubMed ID: 467002
    [No Abstract]   [Full Text] [Related]  

  • 19. beta-Adrenergic receptor-sensitive adenosine cyclic 3',5'-monophosphate accumulation in homogenates of the rat corpus striatum. A comparison with the dopamine receptor-coupled adenylate cyclase.
    Harris JE
    Biochem Pharmacol; 1978; 27(24):2919-25. PubMed ID: 216372
    [No Abstract]   [Full Text] [Related]  

  • 20. A sensitizing d-amphetamine regimen induces long-lasting spinophilin protein upregulation in the rat striatum and limbic forebrain.
    Boikess SR; Marshall JF
    Eur J Neurosci; 2008 Nov; 28(10):2099-107. PubMed ID: 19046390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.